Advertisement

Index by author

November 01, 2004; Volume 32,Issue 11

  1. Takada, Tappei

    1. HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497

  2. Tran, Agnès

    1. IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279

  3. Treluyer, Jean-Marc

    1. IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279

  4. Tucker, G. T.

    1. MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180
Back to top

In this issue

Advertisement